(Q47240432)

12 January 2018

title

Perspective: The clinical trial barriers (English)

1 reference

12 January 2018

author name string

Liang Liu

series ordinal

1

1 reference

12 January 2018

Elaine Lai-Han Leung

series ordinal

2

1 reference

12 January 2018

Xiaoying Tian

series ordinal

3

1 reference

12 January 2018

language of work or name

English

0 references

publication date

21 December 2011

1 reference

12 January 2018

published in

Nature

1 reference

12 January 2018

volume

480

1 reference

12 January 2018

issue

7378

1 reference

12 January 2018

page(s)

S100

1 reference

12 January 2018

https://scigraph.springernature.com/pub.10.1038/480s100a

exact match

0 references

cites work

From genomic landscapes to personalized cancer management-is there a roadmap?

1 reference

Back to the future: why randomized controlled trials cannot be the answer to pharmacogenomics and personalized medicine

21 January 2018

1 reference

Molecular predictors of outcome with gefitinib and docetaxel in previously treated non-small-cell lung cancer: data from the randomized phase III INTEREST trial

21 January 2018

1 reference

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

21 January 2018

1 reference

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

21 January 2018

1 reference

Systems biology-based diagnostic principles as pillars of the bridge between Chinese and Western medicine

21 January 2018

1 reference

Systems biology guided by Chinese medicine reveals new markers for sub-typing rheumatoid arthritis patients

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1038/480S100A

1 reference

12 January 2018

Dimensions Publication ID

1009472346

0 references

1 reference

12 January 2018